BRIDGEWAY CAPITAL MANAGEMENT, LLC - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$69,720
+88.6%
84,0000.0%0.00%
+100.0%
Q1 2023$36,960
-25.4%
84,0000.0%0.00%0.0%
Q4 2022$49,552
-16.0%
84,0000.0%0.00%
-50.0%
Q3 2022$59,000
-51.6%
84,0000.0%0.00%
-33.3%
Q2 2022$122,00084,0000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders